CON-COUR study: Interferential therapy in the treatment of chronic constipation in adults: study protocol for a randomized controlled trial

Véronique Vitton, Alban Benezech, Stéphane Honoré, Patrick Sudour, Nathalie Lesavre, Pascal Auquier, Karine Baumstarck, Véronique Vitton, Alban Benezech, Stéphane Honoré, Patrick Sudour, Nathalie Lesavre, Pascal Auquier, Karine Baumstarck

Abstract

Background: The prevalence of chronic constipation is about 15 % in Western countries with a significant impact on quality of life and health care costs. The first-line therapy, based on medical treatment combined with laxatives and dietary rules, is often disappointing. Interferential therapy is a new treatment that has demonstrated its efficiency in the treatment of chronic constipation in children and encouraging results in adults. The primary objective of this study is to assess the efficacy of interferential therapy during 8 weeks in adult patients. The secondary objectives are to assess this new and noninvasive therapy in terms of persistence of the clinical efficacy, colonic transit time, ano-rectal manometry, patient satisfaction and quality of life (QoL), and tolerance.

Design: multicenter, prospective, randomized, placebo-controlled, double blind, two-parallel groups study.

Setting: nine French adult gastroenterology centers.

Inclusion criteria: adult patients with a history of chronic constipation refractory to medical treatment for at least 3 months. Treatment groups: (1) interferential-experimental group (effective stimulation); (2) placebo-control group (sham stimulation).

Randomization: 1:1 allocation ratio. Evaluation times: inclusion (T0, randomization), baseline assessment (T1), start of stimulation (T2), intermediary assessment (T3, 4 weeks), end of stimulation (T4, 8 weeks), follow-up (T5 and T6, 1- and 6-month).

Endpoints: (1) primary: short-term efficacy at T4 (treatment response defined as three or more spontaneous, complete bowel movements per week); (2) secondary: efficacy at T5 and T6, symptoms (Patient Assessment of Constipation Symptoms questionnaire), colonic transit time, anorectal manometry, patient satisfaction (analogical visual scale), patient QoL (Patient Assessment of Constipation Quality of Life Questionnaire), side/unexpected effects.

Sample size: 200 individuals to obtain 80 % power to detect a 20 % difference in treatment response at T4 between the two groups (15 % of lost to follow-up patients expected).

Discussion: The randomized, double-blind, placebo-controlled design is the most appropriate to demonstrate the efficacy of a new experimental therapeutic (Evidence-Based Medicine Working Group classification). National and international recommendations could be updated based on the findings of this study.

Trial registration: Current controlled trials NCT02381665 (registration date: February 13, 2015).

References

    1. Mugie SM, Benninga MA, Di Lorenzo C. Epidemiology of constipation in children and adults: a systematic review. Best Pract Res Clin Gastroenterol. 2011;25(1):3–18. doi: 10.1016/j.bpg.2010.12.010.
    1. Rao SS. Dyssynergic defecation and biofeedback therapy. Gastroenterol Clin North Am. 2008;37(3):569–86. doi: 10.1016/j.gtc.2008.06.011.
    1. Kamm MA, Dudding TC, Melenhorst J, Jarrett M, Wang Z, Buntzen S, et al. Sacral nerve stimulation for intractable constipation. Gut. 2010;59(3):333–40. doi: 10.1136/gut.2009.187989.
    1. Clarke MC, Chase JW, Gibb S, Robertson VJ, Catto-Smith A, Hutson JM, et al. Decreased colonic transit time after transcutaneous interferential electrical stimulation in children with slow transit constipation. J Pediatr Surg. 2009;44(2):408–12. doi: 10.1016/j.jpedsurg.2008.10.100.
    1. Chase J, Robertson VJ, Southwell B, Hutson J, Gibb S. Pilot study using transcutaneous electrical stimulation (interferential current) to treat chronic treatment-resistant constipation and soiling in children. J Gastroenterol Hepatol. 2005;20(7):1054–61. doi: 10.1111/j.1440-1746.2005.03863.x.
    1. Ismail KA, Chase J, Gibb S, Clarke M, Catto-Smith AG, Robertson VJ, et al. Daily transabdominal electrical stimulation at home increased defecation in children with slow-transit constipation: a pilot study. J Pediatr Surg. 2009;44(12):2388–92. doi: 10.1016/j.jpedsurg.2009.07.063.
    1. Queralto M, Vitton V, Bouvier M, Abysique A, Portier G. Interferential therapy: a new treatment for slow transit constipation. A pilot study in adults. Colorectal Dis. 2013;15(1):e35–9. doi: 10.1111/codi.12052.
    1. Leroi AM, Siproudhis L, Etienney I, Damon H, Zerbib F, Amarenco G, et al. Transcutaneous electrical tibial nerve stimulation in the treatment of fecal incontinence: a randomized trial (CONSORT 1a) Am J Gastroenterol. 2012;107(12):1888–96. doi: 10.1038/ajg.2012.330.
    1. Camilleri M, Kerstens R, Rykx A, Vandeplassche L. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med. 2008;358(22):2344–54. doi: 10.1056/NEJMoa0800670.
    1. Frank L, Kleinman L, Farup C, Taylor L, Miner P., Jr Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol. 1999;34(9):870–7. doi: 10.1080/003655299750025327.
    1. Bouchoucha M, Berger A, Francoual G. Mesure du temps de transit colique total et segmentaire à l'aide d'une seule radiographie de l'abdomen sans préparation et d'un seul type de marqueurs. Gastroenterol Clin Biol. 1989;13:A130.
    1. Marquis P, De La Loge C, Dubois D, McDermott A, Chassany O. Development and validation of the patient assessment of constipation quality of life questionnaire. Scand J Gastroenterol. 2005;40(5):540–51. doi: 10.1080/00365520510012208.
    1. Senn SJ. Cross-over trials in clinical research. Chichester: John Wiley & sons; 2002.
    1. Bennett MI, Hughes N, Johnson MI. Methodological quality in randomised controlled trials of transcutaneous electric nerve stimulation for pain: low fidelity may explain negative findings. Pain. 2011;152(6):1226–32. doi: 10.1016/j.pain.2010.12.009.
    1. Sato A, Sato Y, Sugimoto H, Tervi N. Reflex changes in the urinary bladder after mechanical and thermal stimulation of the skin at various segmental levels in cats. Neuroscience. 1977;2(1):111–7. doi: 10.1016/0306-4522(77)90072-0.
    1. Sato A, Sato Y, Suzuki A, Uchida S. Neural mechanisms of the reflex inhibition and excitation of gastric motility elicited by acupuncture-like stimulation in anesthetized rats. Neurosci Res. 1993;18(1):53–62. doi: 10.1016/0168-0102(93)90105-Y.
    1. Sato A, Schmidt RF. The modulation of visceral functions by somatic afferent activity. Jpn J Physiol. 1987;37(1):1–17. doi: 10.2170/jjphysiol.37.1.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel